Trials / Terminated
TerminatedNCT03108911
Gluten Free Diet in Diminishing Side Effects Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy
Gluten Free Diet for AML Patients Undergoing Induction Chemotherapy
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This randomized phase II trial studies how well a gluten free diet works in diminishing side effects in patients with acute myeloid leukemia undergoing induction chemotherapy. A gluten free diet may result in less intestinal side effects and blood infections during the induction chemotherapy compared to a standard diet.
Detailed description
PRIMARY OBJECTIVES: I. To determine if a gluten free diet (GFD) modulates the rate and severity of bacteremia and gastrointestinal toxicity (measured by total parenteral nutrition \[TPN\] or nothing by mouth \[NPO\] order) in patients undergoing standard acute myeloid leukemia (AML) induction chemotherapy. SECONDARY OBJECTIVES: I. To determine the tolerance of, and compliance with, a GFD in patients undergoing standard AML induction chemotherapy. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I: Patients receive GFD prepared by the hospital per dietary/nutrition pharmacy standards from the initiation of induction chemotherapy until hospital discharge (approximately 30 days). Patients also complete a daily food intake diary. A stool sample is collected from patients at baseline, day 14, and on the day of hospital discharge for gut microbiome analysis. GROUP II: Patients receive a standard diet for from the initiation of induction chemotherapy until hospital discharge (approximately 30 days). Patients also complete a daily food intake diary. A stool sample is collected from patients at baseline, day 14, and on the day of hospital discharge for gut microbiome analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Best Practice | Receive standard diet |
| PROCEDURE | Biospecimen Collection | Provide stool sample |
| OTHER | Dietary Intervention | Receive GFD |
| OTHER | Laboratory Biomarker Analysis | Correlative studies |
Timeline
- Start date
- 2017-07-27
- Primary completion
- 2017-11-14
- Completion
- 2017-11-14
- First posted
- 2017-04-11
- Last updated
- 2017-11-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03108911. Inclusion in this directory is not an endorsement.